Disc Medicine, Inc.
IRON
$92.38
$2.662.97%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.05% | 23.87% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.24% | 53.73% | |||
| Operating Income | -10.24% | -53.73% | |||
| Income Before Tax | -12.73% | -62.50% | |||
| Income Tax Expenses | 96.15% | -56.30% | |||
| Earnings from Continuing Operations | -12.80% | -62.09% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.80% | -62.09% | |||
| EBIT | -10.24% | -53.73% | |||
| EBITDA | -10.25% | -53.60% | |||
| EPS Basic | -12.31% | -54.22% | |||
| Normalized Basic EPS | -12.23% | -54.62% | |||
| EPS Diluted | -12.31% | -54.22% | |||
| Normalized Diluted EPS | -12.23% | -54.62% | |||
| Average Basic Shares Outstanding | 0.44% | 5.10% | |||
| Average Diluted Shares Outstanding | 0.44% | 5.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||